Sensory nerve signals found to block lung cancer immunotherapy

The Neuroimmune Frontier: Redefining How We Fight Lung Cancer

For decades, the battle against lung cancer has focused primarily on two fronts: attacking the tumor directly and boosting the immune system to recognize and destroy malignant cells. However, a groundbreaking discovery from the Francis Crick Institute suggests we have been missing a critical piece of the puzzle—the nervous system.

Researchers have revealed a previously unrecognized neuroimmune connection, discovering that sensory nerve signals can actually interfere with the immune system’s ability to respond to lung cancer. This suggests that the “wiring” of the body may be actively helping tumors evade detection.

The Role of CGRP: The Chemical Messenger Blocking Recovery

The research highlights a specific mechanism where lung tumors stimulate the growth and activity of sensory nerves. These nerves release a chemical messenger known as calcitonin gene-related peptide (CGRP).

Once released, CGRP interacts with macrophages—a type of immune cell—within the tumor microenvironment. This interaction prevents the formation of tertiary lymphoid structures (TLS). These clusters of immune cells are vital because they are closely linked to better outcomes for people living with lung cancer.

By disrupting local sensory nerve activity or blocking CGRP signaling, researchers observed an increase in these protective immune structures, leading to stronger immune responses and a reduction in tumor growth.

Repurposing Medicine: From Migraines to Oncology

One of the most promising trends emerging from this research is the potential for “drug repurposing.” The fight against cancer often requires decades of drug development, but the tools to target CGRP may already exist.

Drugs that inhibit CGRP receptors are already used clinically to treat other conditions, most notably migraines. This opens a quick track for clinical exploration, as scientists investigate whether these existing medications can improve the effectiveness of cancer immunotherapy.

For the many lung cancer patients who do not respond to current immunotherapies, targeting the neuroimmune pathway offers a completely new angle to break through treatment resistance.

Beyond DNA Damage: How Smoking Accelerates Tumor Growth

This proves well-established that smoking is the primary risk factor for lung cancer due to the DNA damage it causes. However, this new research reveals a second, more sinister mechanism: cigarette smoke exploits the neuroimmune interaction.

The study demonstrated that cigarette smoke extract increases neuronal activity, which in turn accelerates tumor progression. In other words smoking doesn’t just start the fire by damaging DNA; it feeds the fire by manipulating the nervous system to suppress the body’s natural immune defenses.

The Future of Interdisciplinary Cancer Research

The merging of neuroscience and immunology is creating a new field of study. This is exemplified by the work of team InteroCANCEption, led by Leanne Li, which has received significant funding—up to £20 million—through the Cancer Grand Challenges initiative.

This initiative, co-founded by The Francis Crick Institute, Cancer Research UK, and the National Cancer Institute in the US, aims to explore the bi-directional connection between the nervous system and tumors. The goal is to move beyond traditional oncology and develop innovative approaches that target the nervous system to expand what is possible in cancer treatment.

Frequently Asked Questions

What is the neuroimmune connection in cancer?
It is the interaction between the nervous system and the immune system. In lung cancer, certain sensory nerves can release chemicals like CGRP that prevent the immune system from organizing effectively against the tumor.

Can migraine medications actually help treat cancer?
While not yet a standard treatment, researchers are exploring this because some migraine drugs block CGRP receptors. Since CGRP helps tumors evade the immune system, blocking it could potentially make immunotherapies more effective.

What are tertiary lymphoid structures (TLS)?
TLS are clusters of immune cells that form within the tumor microenvironment. Their presence is generally associated with better patient outcomes and a more robust immune response against the cancer.

How does smoking affect the nervous system’s role in cancer?
Cigarette smoke extract increases the activity of sensory nerves, which enhances the suppression of the immune response and accelerates the growth of the tumor.